SCHEMBL19861061

SCHEMBL19861061

CCC(C)CC(C)n1c(=O)c(C(=O)O)nc2ccccc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OGFRL1 Q5TC84 10/20 0.53
OPRM1 P35372 8/20 0.53
OPRK1 P41145 7/20 0.53
OPRD1 P41143 5/20 0.53
MAPK1 P28482 2/20 0.48
CASP1 P29466 1/20 0.48
CASP7 P55210 1/20 0.48
ALDH1A1 P00352 7/20 0.45
GLA P06280 2/20 0.44
CYP2C9 P11712 2/20 0.44
CYP2C19 P33261 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
KDM4E B2RXH2 3/20 0.43
HPGD P15428 2/20 0.43
HTT P42858 2/20 0.43
MEN1 O00255 1/20 0.43
CYP3A4 P08684 1/20 0.43
MAPT P10636 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22225553 0.91 OGFRL1 (0.51) OGFRL1OPRM1OPRK1OPRD1MAPK1
SCHEMBL21366177 0.85 OGFRL1 (0.49) OGFRL1OPRM1OPRK1OPRD1MAPK1
SCHEMBL20206668 0.83 ALDH1A1 (0.53) OGFRL1OPRM1OPRK1OPRD1MAPK1
SCHEMBL16382145 0.79 OGFRL1 (0.59) OGFRL1OPRM1OPRK1OPRD1
SCHEMBL21366175 0.78 OGFRL1 (0.46) OGFRL1OPRM1OPRK1OPRD1MAPK1
SCHEMBL21548044 0.76 OGFRL1 (0.49) OGFRL1OPRM1OPRK1OPRD1NR1H4
SCHEMBL21548047 0.76 OGFRL1 (0.49) OGFRL1OPRM1OPRK1OPRD1NR1H4
SCHEMBL16731186 0.75 OGFRL1 (0.46) OGFRL1OPRM1OPRK1OPRD1MAPK1
SCHEMBL10285467 0.74 OGFRL1 (0.50) OGFRL1OPRM1OPRK1OPRD1
SCHEMBL21547994 0.74 OGFRL1 (0.52) OGFRL1OPRM1OPRK1OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9890164-B2 Substituted-quinoxaline-type bridged-piperidine compounds as ORL-1 modulators PURDUE PHARMA, L.P. (US) 2018-02-13 US disclosed